Blueprint Medicines Corp (BPMC) — Cash Flow Reinvestment Rate
Blueprint Medicines Corp (BPMC) has a Cash Flow Reinvestment Rate of 0.69x as of September 2020, reinvesting $430.14 Million (capex $6.00K plus investments $-430.13 Million) from operating cash flow of $622.33 Million. Explore BPMC capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Blueprint Medicines Corp Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Blueprint Medicines Corp across 1 annual periods. Also explore total assets of Blueprint Medicines Corp for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Blueprint Medicines Corp (2020–2020)
Year-by-year capital reinvestment analysis for Blueprint Medicines Corp. For live market cap and broader valuation context, see BPMC market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 1.12x | $434.25 Million | $387.04 Million | $3.16 Million | — |